Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
endometrial cancer
Pharma
Merck's Keytruda turns in mixed results in gynecological cancers
The company unveiled new data from separate studies in late stage cervical cancer and newly diagnosed endometrial cancer.
Zoey Becker
Sep 13, 2024 6:05pm
GSK blows Jemperli marching brass against Keytruda with new nod
Aug 1, 2024 3:00pm
Merck's Keytruda snags 40th US indication
Jun 18, 2024 9:32am
Where's Lynparza in AZ's narrow Imfinzi endometrial cancer nod?
Jun 17, 2024 11:24am
Merck's Keytruda misses the mark in endometrial cancer study
May 9, 2024 10:55am
AZ, GSK make case for broad I-O uses in endometrial cancer
Mar 18, 2024 11:05am
